TMEM127

Chr 2AD

transmembrane protein 127

TMEM127 encodes a transmembrane protein that localizes to endosomes, Golgi, and lysosomes where it participates in protein trafficking and controls cell proliferation by negatively regulating mTORC1 signaling. Mutations cause autosomal dominant susceptibility to pheochromocytoma, typically presenting in adulthood. The gene shows low constraint against loss-of-function variants, which is consistent with its role as a tumor suppressor gene.

OMIMResearchSummary from RefSeq, OMIM, UniProt
LOFmechanismADLOEUF 1.151 OMIM phenotype
Clinical SummaryTMEM127
🧬
Gene-Disease Validity (ClinGen)
hereditary pheochromocytoma-paraganglioma · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.01) — loss-of-function variants are relatively tolerated in the population.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.15LOEUF
pLI 0.013
Z-score 1.29
OE 0.50 (0.251.15)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.45Z-score
OE missense 0.89 (0.771.04)
123 obs / 137.8 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.50 (0.251.15)
00.351.4
Missense OE0.89 (0.771.04)
00.61.4
Synonymous OE1.02
01.21.6
LoF obs/exp: 4 / 7.9Missense obs/exp: 123 / 137.8Syn Z: -0.11
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveTMEM127-related pheochromocytoma, susceptibility toLOFAD
DN
0.4785th %ile
GOF
0.6833th %ile
LOF
0.3551th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and loss-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
LOF1 literature citation

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

LOFYao et al (2010) sequenced the TMEM127 gene in 990 individuals with pheochromocytomas and/or paragangliomas, including 898 previously unreported cases without variants in other susceptibility genes from 8 independent worldwide referral centers. They identified 10 loss of function variants including PMID:21156949

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

TMEM127 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →